Bioavailability and pharmacokinetics of theophylline following plain uncoated and sustained-release dosage forms in relation to smoking habit. II. Multiple dose study
- PMID: 6861849
- DOI: 10.1007/BF00610056
Bioavailability and pharmacokinetics of theophylline following plain uncoated and sustained-release dosage forms in relation to smoking habit. II. Multiple dose study
Similar articles
-
Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.Eur J Clin Pharmacol. 1983;24(1):79-87. doi: 10.1007/BF00613931. Eur J Clin Pharmacol. 1983. PMID: 6832206 Clinical Trial.
-
Absorption of theophylline from conventional and sustained-release tablets.Int J Clin Pharmacol Ther Toxicol. 1981 Mar;19(3):131-8. Int J Clin Pharmacol Ther Toxicol. 1981. PMID: 7228455
-
The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.Int J Clin Pharmacol Ther Toxicol. 1984 Sep;22(9):506-10. Int J Clin Pharmacol Ther Toxicol. 1984. PMID: 6500770
-
A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.Clin Pharmacokinet. 1984 Mar-Apr;9(2):95-135. doi: 10.2165/00003088-198409020-00001. Clin Pharmacokinet. 1984. PMID: 6370542 Review.
-
Slow-release theophylline for the management of chronic asthma.Singapore Med J. 1985 Feb;26(1):83-90. Singapore Med J. 1985. PMID: 3895446 Review. No abstract available.
Cited by
-
Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.Clin Pharmacokinet. 1995 Apr;28(4):287-314. doi: 10.2165/00003088-199528040-00003. Clin Pharmacokinet. 1995. PMID: 7648758 Review.
-
Differential pharmacokinetics of theophylline in elderly patients.Drugs Aging. 2003;20(1):71-84. doi: 10.2165/00002512-200320010-00005. Drugs Aging. 2003. PMID: 12513116 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources